In Vitro studies have shown promise against viruses similar to the bird flu virus. BOSTON, MASSACHUSETTS, (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “ ...
Submit Questions for any of the presenting comp BOSTON, MASSACHUSETTS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company ...
(RTTNews) - Bioxytran Inc. (BIXT), Wednesday announced the development of a groundbreaking treatment to combat Highly Pathogenic Avian Influenza or HPAI, also known as Bird Flu, in egg-laying ...
Register for the Conference here. Submit Questions for any of the presenting comp BOSTON, MASSACHUSETTS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results